Interleukin‐33 alleviates psoriatic inflammation by suppressing the T helper type 17 immune response

Z Chen, Y Hu, Y Gong, X Zhang, L Cui, R Chen… - …, 2020 - Wiley Online Library
Psoriasis is a chronic inflammatory skin disease with unclear pathogenesis. Interleukin‐33
(IL‐33) is highly expressed in patients with psoriasis, but its role in psoriasis is unknown …

Interleukin-33 alleviates psoriatic inflammation by suppressing the T helper type 17 immune response

Z Chen, Y Hu, Y Gong, X Zhang, L Cui… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Psoriasis is a chronic inflammatory skin disease with unclear pathogenesis. Interleukin-33
(IL-33) is highly expressed in patients with psoriasis, but its role in psoriasis is unknown. The …

Interleukin-33 alleviates psoriatic inflammation by suppressing the T helper type 17 immune response.

Z Chen, Y Hu, Y Gong, X Zhang, L Cui, R Chen, Y Yu… - Immunology, 2020 - europepmc.org
Psoriasis is a chronic inflammatory skin disease with unclear pathogenesis. Interleukin-33
(IL-33) is highly expressed in patients with psoriasis, but its role in psoriasis is unknown. The …

[HTML][HTML] Interleukin‐33 alleviates psoriatic inflammation by suppressing the T helper type 17 immune response

Z Chen, Y Hu, Y Gong, X Zhang, L Cui, R Chen, Y Yu… - …, 2020 - ncbi.nlm.nih.gov
Psoriasis is a chronic inflammatory skin disease with unclear pathogenesis. Interleukin‐33
(IL‐33) is highly expressed in patients with psoriasis, but its role in psoriasis is unknown …

Interleukin‐33 alleviates psoriatic inflammation by suppressing the T helper type 17 immune response.

Z Chen, Y Hu, Y Gong, X Zhang, L Cui, R Chen… - …, 2020 - search.ebscohost.com
Psoriasis is a chronic inflammatory skin disease with unclear pathogenesis. Interleukin‐33
(IL‐33) is highly expressed in patients with psoriasis, but its role in psoriasis is unknown …